Journal
NATURAL PRODUCT REPORTS
Volume 36, Issue 9, Pages 1237-1248Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c8np00081f
Keywords
-
Funding
- BBSRC [BB/M017982/1, BB/M022765/1]
- Warwick Integrative Synthetic Biology Centre (WISB), a UK Synthetic Biology Research Centre grant from EPSRC
- BBSRC [BB/M022765/1, BB/M017982/1] Funding Source: UKRI
Ask authors/readers for more resources
Covering: up to December 2018 This article aims to highlight advantages, drawbacks and issues that users should consider when implementing the use of CRISPR/Cas9-tools for genome editing in streptomycetes, the most prolific source of antimicrobial natural products to date. Here, we examine four toolkits that have so far been made available for streptomycete in vivo-engineering and one for in vitro-editing, and review how they have been applied over the last three years. Our critical evaluation of these toolkits intends to support potential users in determining what they could achieve, what they should consider and what system they should select/optimise for their application.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available